113 related articles for article (PubMed ID: 8560451)
21. Effect of Bw4 and Bw6 epitope mismatches on antibody production, acute and chronic rejection, and graft survival in renal allografts.
Leffell MS; Kraus E; Racusen LC; Ratner LE; Charney D; Zachary AA
Transplantation; 2001 Aug; 72(3):433-7. PubMed ID: 11502972
[TBL] [Abstract][Full Text] [Related]
22. Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1.
Sanjanwala B; Draghi M; Norman PJ; Guethlein LA; Parham P
J Immunol; 2008 Nov; 181(9):6293-300. PubMed ID: 18941220
[TBL] [Abstract][Full Text] [Related]
23. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.
Wizel B; Houghten RA; Parker KC; Coligan JE; Church P; Gordon DM; Ballou WR; Hoffman SL
J Exp Med; 1995 Nov; 182(5):1435-45. PubMed ID: 7595214
[TBL] [Abstract][Full Text] [Related]
24. HLA class I variation in Iranian Lur and Kurd populations: high haplotype and allotype diversity with an abundance of KIR ligands.
Ashouri E; Norman PJ; Guethlein LA; Han AS; Nemat-Gorgani N; Norberg SJ; Ghaderi A; Parham P
HLA; 2016 Sep; 88(3):87-99. PubMed ID: 27558013
[TBL] [Abstract][Full Text] [Related]
25. Primary structure shows HLA-B59 to be a hybrid of HLA-B55 and HLA-B51, and not a subtype of HLA-B8.
Hildebrand WH; Domena JD; Parham P
Tissue Antigens; 1993 Apr; 41(4):190-5. PubMed ID: 8362411
[No Abstract] [Full Text] [Related]
26. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity.
Flores-Villanueva PO; Yunis EJ; Delgado JC; Vittinghoff E; Buchbinder S; Leung JY; Uglialoro AM; Clavijo OP; Rosenberg ES; Kalams SA; Braun JD; Boswell SL; Walker BD; Goldfeld AE
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5140-5. PubMed ID: 11309482
[TBL] [Abstract][Full Text] [Related]
27. The clinical importance of variation within the HLA-Bw4 complex.
Collins RW; Harmer AW; Heads AJ; Kondeatis E; Page G; Vaughan RW
Transplantation; 2001 Dec; 72(11):1851-3. PubMed ID: 11740403
[TBL] [Abstract][Full Text] [Related]
28. Allodeterminants and evolution of a novel HLA-B5 CREG antigen, HLA-B SNA.
Sekimata M; Hiraiwa M; Andrien M; Dupont E; Karaki S; Yamamoto J; Kano K; Takiguchi M
J Immunol; 1990 Apr; 144(8):3228-33. PubMed ID: 1691230
[TBL] [Abstract][Full Text] [Related]
29. Characterization of a monoclonal anti-Bw4 antibody (Tü109): evidence for similar epitopes on the Bw4 and Bw6 antigens.
Müller C; Herbst H; Uchanska-Ziegler B; Ziegler A; Schunter F; Steiert I; Muller C; Wernet P
Hum Immunol; 1985 Dec; 14(4):333-49. PubMed ID: 2416720
[TBL] [Abstract][Full Text] [Related]
30. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease.
Burrows SR; Khanna R; Burrows JM; Moss DJ
J Exp Med; 1994 Apr; 179(4):1155-61. PubMed ID: 7511682
[TBL] [Abstract][Full Text] [Related]
31. The primary structure of HLA-A32 suggests a region involved in formation of the Bw4/Bw6 epitopes.
Wan AM; Ennis P; Parham P; Holmes N
J Immunol; 1986 Dec; 137(11):3671-4. PubMed ID: 2431040
[TBL] [Abstract][Full Text] [Related]
32. Alloantibody to a Bw4 epitope in a Bw4+B*27: 05 patient.
Lutz CT; Al-Attar A; May JR; Jennings CD
Transplantation; 2014 Oct; 98(8):853-6. PubMed ID: 24914571
[TBL] [Abstract][Full Text] [Related]
33. HLA-B16 antigens: sequence of the ST-16 antigen, further definition of two B38 subtypes and evidence for convergent evolution of B*3902.
Adams EJ; Martinez-Naves E; Arnett KL; Little AM; Tyan DB; Parham P
Tissue Antigens; 1995 Jan; 45(1):18-26. PubMed ID: 7725307
[TBL] [Abstract][Full Text] [Related]
34. Role of HLA-B*5101 binding nonamer peptides in formation of the HLA-Bw4 public epitope.
Takamiya Y; Sakaguchi T; Miwa K; Takiguchi M
Int Immunol; 1996 Jul; 8(7):1027-34. PubMed ID: 8757948
[TBL] [Abstract][Full Text] [Related]
35. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides.
Sutton J; Rowland-Jones S; Rosenberg W; Nixon D; Gotch F; Gao XM; Murray N; Spoonas A; Driscoll P; Smith M
Eur J Immunol; 1993 Feb; 23(2):447-53. PubMed ID: 7679646
[TBL] [Abstract][Full Text] [Related]
36. Serological demonstration of HLA-Bw4/Bw6 epitopes on hybrid molecules between HLA-B35 and HLA-B51.
Sekimata M; Hayashi H; Nakayama S; Kano K; Takiguchi M
Immunogenetics; 1989; 30(3):229-31. PubMed ID: 2476390
[No Abstract] [Full Text] [Related]
37. The "public" determinants HLA-Bw4/Bw6 do not generate cytotoxic T lymphocytes (CTLs).
López-Larrea C; Arnaiz-Villena A
Cell Immunol; 1989 Oct; 123(2):441-4. PubMed ID: 2790969
[TBL] [Abstract][Full Text] [Related]
38. HLA-B67: a member of the HLA-B16 family that expresses the ME1 epitope.
Little AM; Domena JD; Hildebrand WH; Shen SY; Barber LD; Marsh SG; Bias WB; Parham P
Tissue Antigens; 1994 Jan; 43(1):38-43. PubMed ID: 7517584
[TBL] [Abstract][Full Text] [Related]
39. Molecular mapping of a new public HLA class I epitope shared by all HLA-B and HLA-C antigens and defined by a monoclonal antibody.
Trapani JA; Mizuno S; Kang SH; Yang SY; Dupont B
Immunogenetics; 1989; 29(1):25-32. PubMed ID: 2461903
[TBL] [Abstract][Full Text] [Related]
40. Identification, sequencing and serology of HLA-B*3527.
Guttridge MG; Thompson J; Street J; Darke C
Tissue Antigens; 1999 Apr; 53(4 Pt 1):383-5. PubMed ID: 10323345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
